Yahoo Finance

Recro to Report Financial Results for Third Quarter 2021 on November 9, 2021

SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and ...
Yahoo Finance

Recro To Report Financial Results for Second Quarter 2021 on August 9, 2021

EXTON, Pa., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and ...
Nasdaq

Recro Pharma Announces Effectiveness of Baudax Bio Form 10 Registration Statement

MALVERN, Pa., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a pharmaceutical company with a high-performing revenue generating contract development and manufacturing (CDMO) ...
Nasdaq

Recro Completes Separation of Baudax Bio and Becomes a Dedicated Contract Development and Manufacturing Organization

MALVERN, Pa., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a high-performing, revenue generating contract development and manufacturing organization (CDMO), today announced that ...
Benzinga.com

Recro Expands Development and Manufacturing Relationship With Ensysce Biosciences

GAINESVILLE, Ga., April 15, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. ("Recro"; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and ...
Business Insider

Recro Pharma Provides Regulatory Update for IV Meloxicam

MALVERN, Pa., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care ...
Business Insider

Recro Pharma to Present at the 16th Annual Needham Healthcare Conference

MALVERN, Pa., March 29, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care ...
Business Wire

Robbins Arroyo LLP: Recro Pharma, Inc. (REPH) Misled Shareholders According to a Recently Filed Class Action

SAN DIEGO & MALVERN, Pa.--(BUSINESS WIRE)--Shareholder rights law firm Robbins Arroyo LLP announces that purchasers of Recro Pharma, Inc. (NasdaqCM: REPH) have filed a class action complaint against ...
Benzinga.com

Recro Appoints Eduardo Uribe as Head of Quality for Recro San Diego

SAN DIEGO and GAINESVILLE, Ga., Jan. 19, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. ("Recro"; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex ...